As part of our commitment to rapidly publishing and sharing the results of our COVID-19 study to further research to understand and combat the disease, we are enabling dedicated access to our published COVID-19 GWAS through a branch of our Publication Dataset Access Program. We provide access to de-identified summary statistics from our published COVID-19 GWAS for use in your research through a data transfer agreement. To initiate this process, we ask that you provide a brief description of your research project and list the investigators at your institution who will access the data.
We are committed to supporting researchers, and one way we do this is by enabling access to data we have included in a publication. We provide access to de-identified summary statistics from published 23andMe GWAS for use in your research through a data transfer agreement. To initiate this process, we ask that you provide a brief description of your research project and list the investigators at your institution who will access the data.
The 23andMe Research Innovation Collaborations Program pairs up academic researchers with 23andMe scientists to power genetic discoveries, develop new analysis tools, and improve our interpretation of genetic data. Through this program, academic researchers can work with 23andMe to study de-identified, aggregated data from the 23andMe Research Cohort of millions of participants who have answered survey questions on wide-ranging topics. In particular, we are interested in collaborations that have the potential to catalyze novel findings beyond what we can accomplish on our own. We contribute to meta-analyses or replication of genome-wide association studies, evaluate new methodologies, and explore new data collection tools.